5243482026-01-012026-03-315243482026-03-315243482025-03-315243482025-04-012026-03-315243482026-01-012026-03-31in-capmkt:OtherExpenses1Member5243482025-04-012026-03-31in-capmkt:OtherExpenses1Member5243482026-03-31OtherNoncurrentAssetsDomain15243482026-03-31OtherCurrentFinancialAssetsDomain15243482026-03-31OtherCurrentAssetsDomain15243482026-03-31OtherNoncurrentFinancialLiabilitiesDomain15243482026-03-31OtherCurrentFinancialLiabilitiesDomain15243482026-03-31OtherCurrentLiabilitiesDomain15243482026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15243482026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25243482026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35243482025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15243482025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25243482025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35243482026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares524348AARTIDRUGSNOTLISTEDINE767A01016AARTI DRUGS LIMITEDMain BoardEquity2025-04-012026-03-312026-05-152026-05-08INRLakhsQuarterlyFourth quarterSingle segmentPharmaceuticals2026-05-1514:50:002026-05-1516:40:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated7203000000760000072106000004271900000333200000-10090000032280000081600000180400000141800000065070000007036000000703600000176800000-258000001510000000552600000000055260000027700000580300000551900000655000579600000702000912700000106.056.05006.056.05Notes : <BR> 1. The above results for the Quarter & Period ended 31st March, 2026 have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on 15th May, 2026. <BR> 2. As on March 31, 2026 the Company, has 3 (three) subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, Pinnacle Chile SpA and 2 (two) step down subsidiary, namely Pharma Go SpA., Tripharma Chile SpA. <BR> 3. Company has only one business segment i.e. pharmaceuticals. <BR> 4. Figures for the previous Quarter have been regrouped or rearranged wherever necessary. <BR> 5. The aforesaid Audited Financial Results will be uploaded on the Company's website www.aartidrugs.com and will also be available on the website of BSE Limited www.bseindia.com and the National Stock Exchange of India Limited www.nseindia.com for the benefit of the shareholders and investors. <BR> 6. The figures for the quarter ended March 31, 2026 and quarter ended March 31, 2025 represent the difference between the audited figures in respect of full financial years and the published figures for the nine months ended December 31, 2025 and nine months ended December 31,2024. <BR> <BR> FOR AARTI DRUGS LIMITED <BR> <BR> <BR> Sd/- <BR> Prakash M. Patil <BR> (Chairman, Managing Director&CEO) <BR> DIN: 00005618 <BR> <BR> <BR> Place: Mumbai <BR> Date: 15th May' 2026 <BR> 2025-04-012026-03-31AuditedConsolidated256531000002390000025677000000150401000001150800000-370000012932000003371000006697000005080800000235680000002109000000021090000001328000002680000015960000001949400000000019494000003200000019814000001949200000203000198090000046300091270000010021.3621.360021.3621.36Other Expenses1418000000Other Expenses5080800000106827000002138100000016430000027310000002731000002167000001347490000049078000000829870000072700000154000007000000154700000854850000001221400000146777000002815260000091270000014575900000154886000003700000154923000002568700000000109000002579600000455000008127000000343780000031796000002409000004537900000477880000023750000081959000008739000008120000071500000092225000001266030000028152600000FOR AARTI DRUGS LIMITED <BR> <BR> Sd/- <BR> Prakash M. Patil <BR> (Chairman, Managing Director&CEO) <BR> DIN: 00005618 <BR> <BR> Place: Mumbai <BR> Date: 15th May' 2026Other non-current assets216700000Other current financial assets154700000Other current assets1221400000Other non-current financial liabilities10900000Other current financial liabilities237500000Other current liabilities8739000000-178500000-700000000000-20000000236300000000669700000036600000000-47000000000000005920000021682000000-337100000-11700000-4100000080000025354000000001550000000002800000173320000020000000000000000000000117000000-100000-173410000000000000430300000700000000018170000032300000000-774400000269000000269000004580000072700000Fair value changes on Investments, net28700000Remeasurement of defined benefit Liabiliy/Assets, net-1900000Foreign currency translation reserve90000027700000Fair value changes on Investments, net28700000Remeasurement of defined benefit Liabiliy/Assets, net-1900000Foreign currency translation reserve520000032000000002770000032000000AuditedtrueGokhale & Sathe, Chartered Accountantstrue2027-02-28